ClinicalTrials.Veeva

Menu

VEST Device to Enhance Safein Vein Patency

C

Cardiochirurgia E.H.

Status

Completed

Conditions

Coronary Artery Bypass

Treatments

Device: VEST

Study type

Observational

Funder types

Other

Identifiers

NCT06500897
EHMHVU-001

Details and patient eligibility

About

Purpose - Bypass grafting is the gold standard for severe coronary disease, yet most repeat revascularizations target previously grafted territories. External stenting of saphenous vein grafts, the most frequently used bypass conduit, has been shown to minimize disease markers. This study evaluates clinical outcomes of external stenting in real world routine practice.

Methods - Three centers enrolled a prospective real-world cohort of external- stenting- enhanced CABG patients. All patients received an internal mammary artery graft to the left anterior descending artery and additional arterial and/or venous grafts. One or more venous grafts were externally stented. Choice of conduits, use of cardiopulmonary bypass, and vein harvesting technique were performed according to the routine practice of each surgeon.

All patients were prescribed standard of care medication and were followed via on site visits or phone interviews for major adverse myocardial and cerebral effects.

Enrollment

385 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • CABG with at least one VEST implant

Exclusion criteria

  • none

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems